Cyclerion Therapeutics Inc (NASDAQ:CYCN) has a beta value of 2.04 and has seen 50297.0 shares traded in the last trading session. The company, currently valued at $8.46M, closed the last trade at $3.12 per share which meant it gained $0.09 on the day or 2.97% during that session. The CYCN stock price is -203.53% off its 52-week high price of $9.47 and 59.29% above the 52-week low of $1.27. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.26 million shares traded. The 3-month trading volume is 5.13 million shares.
Cyclerion Therapeutics Inc (NASDAQ:CYCN) trade information
Sporting 2.97% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CYCN stock price touched $3.12 or saw a rise of 27.61%. Year-to-date, Cyclerion Therapeutics Inc shares have moved -3.11%, while the 5-day performance has seen it change -25.89%. Over the past 30 days, the shares of Cyclerion Therapeutics Inc (NASDAQ:CYCN) have changed 3.65%. Short interest in the company has seen 0.14 million shares shorted with days to cover at 0.03.
Cyclerion Therapeutics Inc (CYCN) estimates and forecasts
The company’s shares have gained 4.00% over the past 6 months. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 36.06% over the past 5 years.
CYCN Dividends
Cyclerion Therapeutics Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s Major holders
Insiders own 21.90% of the company shares, while shares held by institutions stand at 16.03% with a share float percentage of 20.53%. Investors are also buoyed by the number of investors in a company, with Cyclerion Therapeutics Inc having a total of 20.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity NASDAQ Composite Index ETF. As of Sep 30, 2024 , the former fund manager holds about 0.87% shares in the company for having 23.49 shares of worth $73288.0 while later fund manager owns 14.5 shares of worth $45233.0 as of Dec 31, 2024 , which makes it owner of about 0.53% of company’s outstanding stock.
